New Approach Methodologies: What Clinical Pharmacologists Should Prepare For

Area of Science:

• Pharmacology
• Toxicology
• Drug Development

Background:

• New Approach Methodologies (NAMs) are increasingly important for regulatory submissions.
• There is a growing need to reduce animal testing in preclinical research.

Purpose of the Study:

• To highlight the critical role of clinical pharmacologists in the adoption of NAMs.
• To emphasize the potential of NAMs to decrease animal use in Investigational New Drug (IND) applications.

Main Methods:

• Collaboration between clinical pharmacologists and preclinical/translational teams.
• Development, quantification, and implementation of NAMs.
• Integration of NAMs into the drug development pipeline.

Main Results:

• Clinical pharmacologists can facilitate the successful integration of NAMs.
• Effective implementation of NAMs can lead to a significant reduction in animal use.
• Enhanced data for early-phase drug development through robust methodologies.

Conclusions:

• Clinical pharmacologists are essential for advancing NAMs in drug development.
• The expertise of clinical pharmacologists is vital for regulatory acceptance of NAMs.
• Adoption of NAMs, supported by clinical pharmacologists, promises more ethical and efficient drug development.